| M&A Sellside | 1758 | Healthcare | Chain of Weight Loss Surgery Centers/Project Belvedere | West | Thriving chain of weight loss surgery centers in high potential markets. | 2020 EBITDAC = $5.8M
2021F EBITDAC = $7.6M |
| Capital Raise Equity | 1676 | Healthcare | Food Supplement Manufacturer/Project Super | Northeast | Contract OTC drug manufacturing and patent-protected superoxide dismutase-related supplements. FDA approval not req. | $200M 2019 Rev.
$40M 2019 EBITDA |
| Capital Raise Debt | 1717 | Technology / Media / Telecom | Telecommunications Software Developer/Project LaSalle | Midwest | Company embeds software on phones to provide useful information about callers and to block spam. | Partnered with Qualcomm |
| Capital Raise Equity | 1704 | Healthcare | Cancer Immunotherapy/Project Remedium | West | Clinical stage pharma with immunotherapy drug platform. Prostate cancer is first indication. | Beginning Phase IIb/III clinical trials |
| M&A Sellside | 1672 | Consumer / Retail | Horticulture Equipment & Supplies Online Retailer/Project Alta | West | Sells equipment and supplies to both commercial and hobbyist cannabis cultivators. Non-plant touching. Unique media-driven strategy reduces CAC. | UNDER EXCLUSIVITY |
| M&A Sellside | 1615 | Technology / Media / Telecom | Multi-Dwelling Unit Broadband Provider/Project Bandwidth | Midwest | Provider of broadband and cable to multi-dwelling units across six states in the Midwest. Contract with building owners, not end users. Some bulk. Low churn. Long term contracts. | 2020 Adj. EBITDA = $1.4M
9,200 passings,
8,700 RGUs
$52.57 ARPU |
| Capital Raise Equity | 1605 | Healthcare | Semiconductor and Electronics Manufacturer/Project Milliard | Midwest | Advanced product authentication technology for logistics and anti-counterfeiting measures; compatible with blockchain and Internet of Things. | Potential for EBITDA > $100M over the next several years |
